CLS-AX
01.12.21
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMDSource: Clearside Biomedical
11.16.20
Clearside Biomedical Announces Data Presentations at the AAO 2020Source: Clearside Biomedical
08.10.20
Clearside Biomedical Announces FDA Acceptance of Investigational NDA for CLS-AX Administered in Suprachoroidal SpaceSource: Clearside Biomedical
06.17.20
Clearside Biomedical Announces Numerous Presentations at ARVO 2020Source: Clearside Biomedical